XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-In Capital
Retained Earnings
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2022   0        
Beginning balance at Dec. 31, 2022 $ 230,076 $ 0 $ 135 $ 115,411 $ 129,534 $ (15,004)
Beginning balance (in shares) at Dec. 31, 2022     13,519,000      
Beginning balance (in shares) at Dec. 31, 2022           1,310,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Compensation expense on common stock options 22     22    
Issuance of restricted stock (in shares)     29,000      
Compensation expense on restricted stock and performance share units 465     465    
Taxes paid related to net shares settlement of equity awards (184)     (184)    
Net income 370       370  
Ending balance (in shares) at Mar. 31, 2023   0        
Ending balance at Mar. 31, 2023 230,749 $ 0 $ 135 115,714 129,904 $ (15,004)
Ending balance (in shares) at Mar. 31, 2023     13,548,000      
Ending balance (in shares) at Mar. 31, 2023           1,310,000
Beginning balance (in shares) at Dec. 31, 2022   0        
Beginning balance at Dec. 31, 2022 230,076 $ 0 $ 135 115,411 129,534 $ (15,004)
Beginning balance (in shares) at Dec. 31, 2022     13,519,000      
Beginning balance (in shares) at Dec. 31, 2022           1,310,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 3,045          
Ending balance (in shares) at Sep. 30, 2023   0        
Ending balance at Sep. 30, 2023 233,965 $ 0 $ 136 116,254 132,579 $ (15,004)
Ending balance (in shares) at Sep. 30, 2023     13,688,000      
Ending balance (in shares) at Sep. 30, 2023           1,310,000
Beginning balance (in shares) at Mar. 31, 2023   0        
Beginning balance at Mar. 31, 2023 230,749 $ 0 $ 135 115,714 129,904 $ (15,004)
Beginning balance (in shares) at Mar. 31, 2023     13,548,000      
Beginning balance (in shares) at Mar. 31, 2023           1,310,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Compensation expense on common stock options 30     30    
Issuance of restricted stock (in shares)     140,000      
Issuance of restricted stock 0   $ 1 (1)    
Compensation expense on restricted stock and performance share units 1,100     1,100    
Taxes paid related to net shares settlement of equity awards (798)     (798)    
Net income 504       504  
Ending balance (in shares) at Jun. 30, 2023   0        
Ending balance at Jun. 30, 2023 231,585 $ 0 $ 136 116,045 130,408 $ (15,004)
Ending balance (in shares) at Jun. 30, 2023     13,688,000      
Ending balance (in shares) at Jun. 30, 2023           1,310,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Compensation expense on common stock options 22     22    
Compensation expense on restricted stock and performance share units 187     187    
Net income 2,171       2,171  
Ending balance (in shares) at Sep. 30, 2023   0        
Ending balance at Sep. 30, 2023 $ 233,965 $ 0 $ 136 116,254 132,579 $ (15,004)
Ending balance (in shares) at Sep. 30, 2023     13,688,000      
Ending balance (in shares) at Sep. 30, 2023           1,310,000
Beginning balance (in shares) at Dec. 31, 2023 0 0        
Beginning balance at Dec. 31, 2023 $ 235,894 $ 0 $ 137 116,480 134,281 $ (15,004)
Beginning balance (in shares) at Dec. 31, 2023 13,688,000   13,688,000      
Beginning balance (in shares) at Dec. 31, 2023 1,310,000         1,310,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Compensation expense on common stock options $ 29     29    
Compensation expense on restricted stock and performance share units 245     245    
Taxes paid related to net shares settlement of equity awards (in shares)     6,000      
Net income 5,098       5,098  
Ending balance (in shares) at Mar. 31, 2024   0        
Ending balance at Mar. 31, 2024 $ 241,266 $ 0 $ 137 116,754 139,379 $ (15,004)
Ending balance (in shares) at Mar. 31, 2024     13,694,000      
Ending balance (in shares) at Mar. 31, 2024           1,310,000
Beginning balance (in shares) at Dec. 31, 2023 0 0        
Beginning balance at Dec. 31, 2023 $ 235,894 $ 0 $ 137 116,480 134,281 $ (15,004)
Beginning balance (in shares) at Dec. 31, 2023 13,688,000   13,688,000      
Beginning balance (in shares) at Dec. 31, 2023 1,310,000         1,310,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of common stock options (in shares) 6,667          
Net income $ 14,362          
Ending balance (in shares) at Sep. 30, 2024 0 0        
Ending balance at Sep. 30, 2024 $ 251,186 $ 0 $ 137 117,410 148,643 $ (15,004)
Ending balance (in shares) at Sep. 30, 2024 13,741,000   13,741,000      
Ending balance (in shares) at Sep. 30, 2024 1,310,000         1,310,000
Beginning balance (in shares) at Mar. 31, 2024   0        
Beginning balance at Mar. 31, 2024 $ 241,266 $ 0 $ 137 116,754 139,379 $ (15,004)
Beginning balance (in shares) at Mar. 31, 2024     13,694,000      
Beginning balance (in shares) at Mar. 31, 2024           1,310,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Compensation expense on common stock options 46     46    
Issuance of restricted stock (in shares)     33,000      
Issuance of restricted stock 0   0    
Compensation expense on restricted stock and performance share units 196     196    
Taxes paid related to net shares settlement of equity awards (98)     (98)    
Net income 4,250       4,250  
Ending balance (in shares) at Jun. 30, 2024   0        
Ending balance at Jun. 30, 2024 245,660 $ 0 $ 137 116,898 143,629 $ (15,004)
Ending balance (in shares) at Jun. 30, 2024     13,727,000      
Ending balance (in shares) at Jun. 30, 2024           1,310,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of common stock options (in shares)     7,000      
Exercise of common stock options 70     70    
Compensation expense on common stock options 66     66    
Issuance of restricted stock (in shares)     7,000      
Compensation expense on restricted stock and performance share units 456     456    
Taxes paid related to net shares settlement of equity awards (80)     (80)    
Net income $ 5,014       5,014  
Ending balance (in shares) at Sep. 30, 2024 0 0        
Ending balance at Sep. 30, 2024 $ 251,186 $ 0 $ 137 $ 117,410 $ 148,643 $ (15,004)
Ending balance (in shares) at Sep. 30, 2024 13,741,000   13,741,000      
Ending balance (in shares) at Sep. 30, 2024 1,310,000         1,310,000